943 related articles for article (PubMed ID: 21653305)
1. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.
Gupta N; Limbago BM; Patel JB; Kallen AJ
Clin Infect Dis; 2011 Jul; 53(1):60-7. PubMed ID: 21653305
[TBL] [Abstract][Full Text] [Related]
2. Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases--United States, 2010-2015.
Lyman M; Walters M; Lonsway D; Rasheed K; Limbago B; Kallen A
MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(47):1315-6. PubMed ID: 26633574
[TBL] [Abstract][Full Text] [Related]
3. Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae.
Chea N; Bulens SN; Kongphet-Tran T; Lynfield R; Shaw KM; Vagnone PS; Kainer MA; Muleta DB; Wilson L; Vaeth E; Dumyati G; Concannon C; Phipps EC; Culbreath K; Janelle SJ; Bamberg WM; Guh AY; Limbago B; Kallen AJ
Emerg Infect Dis; 2015 Sep; 21(9):1611-6. PubMed ID: 26290955
[TBL] [Abstract][Full Text] [Related]
4. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
[TBL] [Abstract][Full Text] [Related]
5. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.
Nordmann P
Med Mal Infect; 2014 Feb; 44(2):51-6. PubMed ID: 24360201
[TBL] [Abstract][Full Text] [Related]
6. [KPC carbapenemases: what is at stake in clinical microbiology?].
Cuzon G; Naas T; Nordmann P
Pathol Biol (Paris); 2010 Feb; 58(1):39-45. PubMed ID: 19854586
[TBL] [Abstract][Full Text] [Related]
7. Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceae reveals Intergenus KPC carbapenemase transmission through a promiscuous plasmid.
Mathers AJ; Cox HL; Kitchel B; Bonatti H; Brassinga AK; Carroll J; Scheld WM; Hazen KC; Sifri CD
mBio; 2011; 2(6):e00204-11. PubMed ID: 22045989
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States.
Guh AY; Limbago BM; Kallen AJ
Expert Rev Anti Infect Ther; 2014 May; 12(5):565-80. PubMed ID: 24666262
[TBL] [Abstract][Full Text] [Related]
9. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
Tängdén T; Giske CG
J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628
[TBL] [Abstract][Full Text] [Related]
10. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
Stock I
Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
[TBL] [Abstract][Full Text] [Related]
11. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
Logan LK
Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
[TBL] [Abstract][Full Text] [Related]
12. [Carbapenemases in enterobacteriaceae].
Nordmann P; Carrer A
Arch Pediatr; 2010 Sep; 17 Suppl 4():S154-62. PubMed ID: 20826325
[TBL] [Abstract][Full Text] [Related]
13. Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001-2010.
Zarfel G; Hoenigl M; Würstl B; Leitner E; Salzer HJ; Valentin T; Posch J; Krause R; Grisold AJ
Clin Microbiol Infect; 2011 Nov; 17(11):E5-8. PubMed ID: 21939472
[TBL] [Abstract][Full Text] [Related]
14. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):256-60. PubMed ID: 19300408
[TBL] [Abstract][Full Text] [Related]
15. New Delhi Metallo-β-lactamase and other mechanisms of carbapenemases among Enterobacteriaceae in rural South India.
Sekar R; Srivani S; Kalyanaraman N; Thenmozhi P; Amudhan M; Lallitha S; Mythreyee M
J Glob Antimicrob Resist; 2019 Sep; 18():207-214. PubMed ID: 31181271
[TBL] [Abstract][Full Text] [Related]
16. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.
Logan LK; Weinstein RA
J Infect Dis; 2017 Feb; 215(suppl_1):S28-S36. PubMed ID: 28375512
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds.
Pournaras S; Poulou A; Tsakris A
J Antimicrob Chemother; 2010 Jul; 65(7):1319-21. PubMed ID: 20395214
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat.
Lutgring JD
Semin Diagn Pathol; 2019 May; 36(3):182-186. PubMed ID: 31056277
[TBL] [Abstract][Full Text] [Related]
19. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Goodman KE; Simner PJ; Tamma PD; Milstone AM
Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
[TBL] [Abstract][Full Text] [Related]
20. [Carbapenem-resistant Klebsiella pneumoniae following foreign travel].
Leverstein-van Hall MA; Stuart JC; Voets GM; Versteeg D; Roelofsen E; Fluit AC
Ned Tijdschr Geneeskd; 2010; 154():A2013. PubMed ID: 20858323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
